Martin Shkreli shorts Hims & Hers stock, calling its peptides fake medicine.

Martin Shkreli shorts Hims & Hers stock, calling its peptides fake medicine.

Hims & Hers Health is in focus Friday after an FDA advisory panel on Thursday recommended adding four peptides to a federal compounding list.